Qing Wen
Jinan Central Hospital · Hematology Medical Center, the Second Affiliated Hospital of PLA Army Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Qing Wen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:51 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07330531 · Drug-drug Interaction Study of Rifampin and Anaprazole SodiumXuanzhu Biopharmaceutical Co., Ltd. · not yet recruiting · Drug-drug Interaction Study · principal investigator
- N/ANCT06983665 · Human Bioequivalence Study of Liposomal Amphotericin B for InjectionSichuan Huiyu Pharmaceutical Co., Ltd · completed · Invasive Fungal Infections, Neutropenic Fever, Visceral Leishmaniasis · study director
- N/ANCT06977490 · Human Bioequivalence Study of Amphotericin B Liposome for InjectionSichuan Huiyu Pharmaceutical Co., Ltd · completed · Invasive Fungal Infections, Neutropenic Fever, Visceral Leishmaniasis · study director
- Ph1NCT06822153 · Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the HeartAhon Pharmaceutical Co., Ltd. · completed · QT Interval, Variation in · principal investigator
- Ph1NCT06614907 · A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent®Qilu Pharmaceutical Co., Ltd. · completed · Atopic Dermatitis · principal investigator
- Ph1NCT06412185 · Single Dose Escalation Study of CM383 in Healthy VolunteersKeymed Biosciences Co.Ltd · unknown · Alzheimer Disease · principal investigator
- N/ANCT05936086 · A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLHshifeng Lou · recruiting · Hemophagocytic Syndrome · study director
- Ph1NCT05866354 · To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid MalignanciesZai Lab (Shanghai) Co., Ltd. · completed · Solid Malignancies · principal investigator
- Ph1NCT05399030 · A Phase I Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical Study of ICP-332 in Healthy SubjectsBeijing InnoCare Pharma Tech Co., Ltd. · completed · Healthy Subjects · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:51 UTC. The ranking covers the 200 most relevant of 92 PubMed records, and a shared surname and initials can bring in a namesake. All 92 on PubMed
- The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey.J Bone Miner Res · 2019289 citationsRCR 16.3
- 168 citationsRCR 6.0
- 146 citationsRCR 5.9
- Effect of providing near glasses on productivity among rural Indian tea workers with presbyopia (PROSPER): a randomised trial.Lancet Glob Health · 2018114 citationsRCR 7.8
- 79 citationsRCR 3.5
- 63 citationsRCR 7.0
- 61 citationsRCR 8.7
- G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant · 201957 citationsRCR 2.3
- Improvement of poststroke cognitive impairment by intermittent theta bursts: A double-blind randomized controlled trial.Brain Behav · 202252 citationsRCR 5.9
- Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.Int J Radiat Oncol Biol Phys · 202338 citationsRCR 4.3